UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Choice of surrogate and physiological markers for prenatal gene therapy.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Journal Article
  • Authors:
    Delhove JMKM, Rahim AA, McKay TR, Waddington SN, Buckley SMK
  • Publication date:
    2012
  • Pagination:
    273, 290
  • Journal:
    Methods Mol Biol
  • Volume:
    891
  • Status:
    Published
  • Country:
    United States
  • Language:
    eng
  • Keywords:
    Alkaline Phosphatase, Animals, Biomarkers, DNA, Enzyme Assays, Enzyme-Linked Immunosorbent Assay, Factor IX, Genetic Therapy, Genetic Vectors, Green Fluorescent Proteins, Humans, Immunohistochemistry, Luciferases, Firefly, Mice, Polymerase Chain Reaction, Prenatal Care, Staining and Labeling, Tissue Extracts, Whole Body Imaging, beta-Galactosidase
Abstract
Surrogate genetically encoded markers have been utilized in order to analyze gene transfer efficacy, location, and persistence. These marker genes have greatly accelerated the development of gene transfer vectors for the ultimate application of gene therapy using therapeutic genes. They have also been used in many other applications, such as gene marking in order to study developmental cell lineages, to track cell migration, and to study tumor growth and metastasis. This chapter aims to describe the analysis of several commonly used marker genes: green fluorescent protein (GFP), β-galactosidase, firefly luciferase, human factor IX, and alkaline phosphatase. The merits and disadvantages of each are briefly discussed. In addition a few short examples are provided for continual and endpoint analysis in different disease models including hemophilia, cystic fibrosis, ornithine transcarbamylase deficiency and Gaucher disease.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Maternal & Fetal Medicine
Author
Pharmacology
Author
Maternal & Fetal Medicine
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by